戊糖片球菌治疗婴儿肠绞痛的临床研究概述

doi:10.3969/j.issn.1674-8115.2022.11.017

上海交通大学学报（医学版） ›› 2022, Vol. 42 ›› Issue (11): 1633-1637.doi: 10.3969/j.issn.1674-8115.2022.11.017

• 综述 • 上一篇

戊糖片球菌治疗婴儿肠绞痛的临床研究概述

吴诗寅(), 蔡美琴()

上海交通大学公共卫生学院，上海 200025

收稿日期:2022-06-17 接受日期:2022-10-18 出版日期:2022-11-28 发布日期:2023-01-04
通讯作者: 蔡美琴 E-mail:shiyin98@163.com;caimeiqin@sjtu.edu.cn
作者简介:吴诗寅（1998—），女，硕士生；电子信箱：shiyin98@163.com。

Summary of clinical research of Pediococcus pentosaceus in treatment of infantile colic

WU Shiyin(), CAI Meiqin()

Shanghai Jiao Tong University School of Public Health, Shanghai 200025, China

Received:2022-06-17 Accepted:2022-10-18 Online:2022-11-28 Published:2023-01-04
Contact: CAI Meiqin E-mail:shiyin98@163.com;caimeiqin@sjtu.edu.cn

摘要/Abstract

摘要：

婴儿肠绞痛是一种常见病，其病因尚未明确，可能与肠道菌群失调有关。戊糖片球菌是乳酸菌科片球菌属的益生菌，具有增强宿主免疫力、改善肠道菌群多样性等作用。该文对戊糖片球菌的抑菌能力、肠道定植能力和抗生素敏感性等益生菌特性及其抗氧化、抗病毒和免疫调节等益生功能进行介绍，并阐述婴儿肠绞痛的可能发病机制、戊糖片球菌治疗婴儿肠绞痛的功效和潜在作用机制，以及国内外临床研究现状，以期为戊糖片球菌治疗婴儿肠绞痛提供科学依据。

关键词: 戊糖片球菌, 婴儿肠绞痛, 益生特性

Abstract:

Infantile colic is a common disease. Its etiology is not clear, which may be related to the imbalance of intestinal flora. Pediococcus pentosaceus is a probiotic of Pediococcus of Lactobacillaceae. It can enhance host immunity and improve the diversity of intestinal flora. This paper will introduce the characteristics of probiotics such as antibacterial capability, intestinal colonization ability and antibiotic sensitivity of Pediococcus pentosaceus, and the probiotic functions such as antioxidant, antiviral and immune regulation, and elaborate on the possible pathogenesis of infantile colic, the efficacy and potential mechanism of Pediococcus pentosaceus in the treatment of infantile colic, and the current situation of clinical research at home and abroad, in order to provide a scientific basis for Pediococcus pentosaceus in the treatment of infantile colic.

Key words: Pediococcus pentosaceus, infantile colic, probiotic characteristics

中图分类号:

R722.19

吴诗寅, 蔡美琴. 戊糖片球菌治疗婴儿肠绞痛的临床研究概述[J]. 上海交通大学学报（医学版）, 2022, 42(11): 1633-1637.

WU Shiyin, CAI Meiqin. Summary of clinical research of Pediococcus pentosaceus in treatment of infantile colic[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(11): 1633-1637.

参考文献 30

1	JI W J, LIANG A M, QU C Y, et al. Epidemiologic survey on the prevalence and distribution of infants′ common gastrointestinal symptoms in 7 cities in China: a population-based study[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2018, 39(9): 1179-1183.
2	ZAIKA L L, KISSINGER J C. Fermentation enhancement by spices: identification of active component[J]. J Food Sci, 1984, 49(1): 5-9.
3	PEDEBSON C S, Albury M N. Sauerkraut[J]. Adv Food Res, 1961, 10: 233-291.
4	EFSA Panel on Biological Hazards (BIOHAZ), KOUTSOUMANIS K, ALLENDE A, et al. Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 12: suitability of taxonomic units notified to EFSA until March 2020[J]. Efsa J, 2020, 18(7): e06174.
5	LADHA G, JEEVARATNAM K. Characterization of purified antimicrobial peptide produced by Pediococcus pentosaceus LJR1, and its application in preservation of white leg shrimp[J]. World J Microbiol Biotechnol, 2020, 36(5): 72.
6	裴慧洁. 戊糖片球菌产细菌素的提取、分离纯化及理化特性研究[D]. 扬州:扬州大学, 2019.
	PEI H J. Extraction, purification and physicochemical properties of bacteriocin produced by Pediococcus pentosaceus[D].Yangzhou: Yangzhou University, 2019.
7	QUEIROZ L L, HOFFMANN C, LACORTE G A, et al. Genomic and functional characterization of bacteriocinogenic lactic acid bacteria isolated from Boza, a traditional cereal-based beverage[J]. Sci Rep, 2022, 12(1): 1460.
8	LU Y, HAN S, ZHANG S, et al. The role of probiotic exopolysaccharides in adhesion to mucin in different gastrointestinal conditions[J]. Curr Res Food Sci, 2022, 5: 581-589.
9	谷懿寰, 江正强, 刘军, 等. 奶豆腐中戊糖片球菌的分离鉴定及其产胞外多糖的益生活性[J]. 食品与发酵工业, 2022, 48(9): 84-90.
	GU Y H, JIANG Z Q,LIU J, et al. Separation and identification of Pediococcus pentosaceus S28 from dried milk cake and the prebiotic activity of its exopolysaccharides[J].Food Ferment Industr, 2022, 48(9): 84-90.
10	QI Y, HUANG L, ZENG Y, et al. Pediococcus pentosaceus: screening and application as probiotics in food processing[J]. Front Microbiol, 2021, 12: 762467.
11	ASTÓ E, HUEDO P, ALTADILL T, et al. Probiotic properties of Bifidobacterium longum KABP042 and Pediococcus pentosaceus KABP041 show potential to counteract functional gastrointestinal disorders in an observational pilot trial in infants[J]. Front Microbiol, 2021, 12: 741391.
12	LV L X, LI Y D, HU X J, et al. Whole-genome sequence assembly of Pediococcus pentosaceus LI05 (CGMCC 7049) from the human gastrointestinal tract and comparative analysis with representative sequences from three food-borne strains[J]. Gut Pathog, 2014, 6: 36.
13	ZHANG H, XU J, CHEN Q, et al. Physiological, morphological and antioxidant responses of Pediococcus pentosaceus R1 and Lactobacillus fermentum R6 isolated from Harbin dry sausages to oxidative stress[J]. Foods, 2021, 10(6): 1203.
14	LEE D K, PARK J E, KIM M J, et al. Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients[J]. Clin Res Hepatol Gastroenterol, 2015, 39(2): 237-244.
15	MARTÍN V, MALDONADO A, FERNÁNDEZ L, et al. Inhibition of human immunodeficiency virus type 1 by lactic acid bacteria from human breastmilk[J]. Breastfeed Med, 2010, 5(4): 153-158.
16	ALPDUNDAR BULUT E, BAYYURT KOCABAS B, YAZAR V, et al. Human gut commensal membrane vesicles modulate inflammation by generating M2-like macrophages and myeloid-derived suppressor cells[J]. J Immunol, 2020, 205(10): 2707-2718.
17	SANTAS J, FUENTES M C, TORMO R, et al. Pediococcus pentosaceus CECT 8330 and Bifidobacterium longum CECT 7894 show a trend towards lowering infantile excessive crying syndrome in a pilot clinical trial[J]. Int J Pharma Bio Sci, 2015, 6(2): 458-466.
18	HUANG J, LI S, WANG Q, et al. Pediococcus pentosaceus B49 from human colostrum ameliorates constipation in mice[J]. Food Funct, 2020, 11(6): 5607-5620.
19	WANG R, DENG Y, ZHANG Y, et al. Modulation of intestinal barrier, inflammatory response, and gut microbiota by Pediococcus pentosaceus zy-B alleviates Vibrio parahaemolyticus infection in C57BL/6J mice[J]. J Agric Food Chem, 2022, 70(6): 1865-1877.
20	陈霞, 刘芳丽, 王莹, 等. 婴儿肠绞痛研究进展[J]. 中国儿童保健杂志, 2021, 29(9): 973-977.
	CHEN X, LIU F L, WANG Y. Research progress of infant colic[J]. Chin J Child Health Care, 2021, 29(9): 973-977.
21	TINTORE M, COLOME G, SANTAS J, et al. Gut microbiota dysbiosis and role of probiotics in infant colic[J]. Arch Clin Microbiol, 2017, 8(4). DOI: 10.4172/1989-8436.100056.
22	HOFMAN D, KUDLA U, MIQDADY M, et al. Faecal microbiota in infants and young children with functional gastrointestinal disorders: a systematic review[J]. Nutrients, 2022, 14(5): 974.
23	ZEEVENHOOVEN J, BROWNE P D, L'HOIR M P, et al. Infant colic: mechanisms and management[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(8): 479-496.
24	PÄRTTY A, KALLIOMÄKI M, SALMINEN S, et al. Infantile colic is associated with low-grade systemic inflammation[J]. J Pediatr Gastroenterol Nutr, 2017, 64(5): 691-695.
25	JOHNSON J M, ADAMS E D. The gastrointestinal microbiome in infant colic: a scoping review[J]. MCN Am J Matern Child Nurs, 2022, 47(4): 195-206.
26	DONG F, XIAO F, LI X, et al. Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice[J]. J Transl Med, 2022, 20(1): 33.
27	JIANG S, XIA J, LV L, et al. Effects of Pediococcus pentosaceus LI05 on immunity and metabolism in germ-free rats[J]. Food Funct, 2021, 12(11): 5077-5086.
28	CHEN K, LIU C, LI H, et al. Infantile colic treated with Bifidobacterium longum CECT7894 and Pediococcus pentosaceus CECT8330: a randomized, double-blind, placebo-controlled trial[J]. Front Pediatr, 2021, 9: 635176.
29	TINTORE M, CUNE J. Probiotic treatment with ab-kolicare^® causes changes in the microbiota which correlate with a reduction in crying time[J]. Int J Pharma Bio Sci, 2017, 8(1): 281-288.
30	NAVARRO-TAPIA E, STICCO M, ASTó E, et al. Patient characteristics influencing infant colic amelioration under a probiotic treatment[J]. Ann Nutr Metabol, 2019, 74(suppl 1): 15.

[1]	陈江龙, 陈砼, 吕志宝, 王雪莉, 盛庆丰. miR-146a-5p表达与新生儿坏死性小肠结肠炎肠道损伤严重程度的相关研究[J]. 上海交通大学学报(医学版), 2021, 41(9): 1147-1153.
[2]	王朋朋，朱晓东，谢伟. 胎粪性腹膜炎的临床特征及预后相关因素分析[J]. 上海交通大学学报(医学版), 2020, 40(5): 662-665.
[3]	李文 1，谈珍 2，刘成博 1，王铮涛 3，张拥军 1. 黄芪多糖APS- Ⅱ- 2对脂多糖所致绒毛膜羊膜炎诱发的肺泡化阻滞的改善作用[J]. 上海交通大学学报（医学版）, 2018, 38(4): 374-.
[4]	陈江龙, 陈砼, 吕志宝, 王雪莉, 盛庆丰. miR-146a-5p表达与新生儿坏死性小肠结肠炎肠道损伤严重程度的相关研究[J]. 上海交通大学学报(医学版), 0, (): 1-7.

戊糖片球菌治疗婴儿肠绞痛的临床研究概述

Summary of clinical research of Pediococcus pentosaceus in treatment of infantile colic

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 30

相关文章 4

编辑推荐

Metrics